Remodelin, as a novel tiny molecule, continues to be proven to lower NAT10 activity11, thus avoiding mRNA acetylation, and has long been proven for being a powerful treatment for different different types of tumors2. Inside our previous study12, it had been located that Remodelin can inhibit The expansion of OS by suppressing the expression of NAT1